Key Takeaways
- • International Flavors & Fragrances (IFF) agreed to sell its Food Ingredients business to CVC Capital Partners for $4.3 billion, while retaining a 10% minority equity stake worth approximately $200 million.
- • The Food Ingredients business generated $3.1 billion in annual sales and $430 million of EBITDA in 2025, representing a significant revenue stream for the divested unit.
- • IFF will use proceeds to reduce debt and refocus on higher-growth, higher-margin segments: Taste, Scent, and Health & Biosciences, accelerating R&D investment and biotechnology integration.
- • The minority retention allows IFF shareholders to participate in future value creation under CVC's ownership while simplifying the parent company's portfolio and operational complexity.
Summary
IFF has entered into a definitive agreement to divest its Food Ingredients business to funds advised by CVC Capital Partners at an enterprise valuation of $4.3 billion. The transaction represents a strategic portfolio rationalization move designed to strengthen IFF's focus on innovation-driven segments where the company believes it can generate superior margins and growth. CEO Erik Fyrwald characterized the deal as "an important strategic milestone in our ongoing portfolio optimization initiative," emphasizing that the sale will allow IFF to concentrate capital and resources on Taste, Scent, and Health & Biosciences—segments the company views as higher-growth and higher-margin opportunities.
The Food Ingredients unit is a substantial business in its own right, having generated nearly $3.1 billion in revenue and approximately $430 million of EBITDA during 2025. The division produces texturants, emulsifiers, plant-based solutions, and specialty ingredients serving multinational food and beverage manufacturers. Despite divesting the business, IFF has structured a minority retention arrangement, keeping a 10% equity stake valued at approximately $200 million. This structure permits continued collaboration between IFF and the divested entity while enabling IFF shareholders to capture upside from the business under CVC's dedicated ownership.
The transaction underscores IFF's broader strategic shift toward higher-margin specialty segments and reflects the company's intention to accelerate innovation and R&D spending in biotechnology and naturals capabilities. According to Fyrwald, the simplified portfolio will allow IFF to "drive sustained, profitable long-term growth" while leveraging the sale proceeds to reduce leverage and strengthen the balance sheet. The deal involves leading legal and financial advisors, including White & Case and Skadden on the acquisition side, positioning this as a complex, institutional-grade transaction that is expected to close subject to customary closing conditions.
The Food Ingredients unit is a substantial business in its own right, having generated nearly $3.1 billion in revenue and approximately $430 million of EBITDA during 2025. The division produces texturants, emulsifiers, plant-based solutions, and specialty ingredients serving multinational food and beverage manufacturers. Despite divesting the business, IFF has structured a minority retention arrangement, keeping a 10% equity stake valued at approximately $200 million. This structure permits continued collaboration between IFF and the divested entity while enabling IFF shareholders to capture upside from the business under CVC's dedicated ownership.
The transaction underscores IFF's broader strategic shift toward higher-margin specialty segments and reflects the company's intention to accelerate innovation and R&D spending in biotechnology and naturals capabilities. According to Fyrwald, the simplified portfolio will allow IFF to "drive sustained, profitable long-term growth" while leveraging the sale proceeds to reduce leverage and strengthen the balance sheet. The deal involves leading legal and financial advisors, including White & Case and Skadden on the acquisition side, positioning this as a complex, institutional-grade transaction that is expected to close subject to customary closing conditions.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.